Ustekinumab plus dupilumab in the treatment of concomitant psoriasis and prurigo nodularis

J Eur Acad Dermatol Venereol. 2022 Dec;36(12):e1050-e1051. doi: 10.1111/jdv.18445. Epub 2022 Jul 27.

Authors

M Kabbani¹, G Mboyo Mpita¹, Farida Benhadou¹

Affiliation

¹ Department of Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.

PMID: 35857380
DOI: 10.1111/jdv.18445

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Humans
Prurigo* / complications
Prurigo* / drug therapy
Psoriasis* / complications
Psoriasis* / drug therapy
Ustekinumab / therapeutic use

Substances

dupilumab
Ustekinumab
Antibodies, Monoclonal, Humanized